netFormulary NHS Crawley and NHS Horsham and Mid Sussex CCG NHS
 Formulary Chapter 16: Medicines Management Website information - Full Chapter

Includes guidelines and advice, PGDs, audit tools, template letters and link to drug tariff specials.

Chapter Links...
16.03  Expand sub section  Patient Group Directions (PGD's)

Patient Group Directions (PGD's)

Patient group directions (PGDs) provide a legal framework for health care professionals, such as nurses and pharmacists, to supply and administer medicines without the need for a prescription or instructions from a prescriber.

From January 2019, all the PGDs approved by NHS England can be accessed on the NHSE South East webpage. Please follow the link below to access the PGDs for the following vaccination programmes:

  • Routine Childhood Immunisation Programme
  • Adult Vaccination Programmes
  • Travel Health related vaccination programmes

Link to the NHSE South East PGD Page:

Additional information such as FAQs is also available under the PGD section. Practitioners can also access the Green Book via this page. All information around the UK Vaccination programme is available from the Green Book and on the PHE webpage:

If you have a query on Immunisation and vaccination programmes or the NHS England PGDs, please see signposting information or contact the local Public Health Screening and Immunisation Team, who are based at the NHS England offices in Horley (01138 255548 /

note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Track Changes
Display tracking information
click to search
Link to adult BNF
click to search
Link to children's BNF
click to search
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHS England

Traffic Light Status Information

Status Description


Comment : Not routinely commissioned in any care setting. This may be due to a lack of good clinical evidence, cost effectiveness, concerns over safety or due to the availability of more suitable alternatives. Deviation from this position may be considered by prescribers on an individual basis, where exceptional circumstances exist. Otherwise, funding via Individual Funding Request (IFR) only.   


Initiation : Specialist or hospital only
Repeat Prescribing : Specialist or hospital only
Monitoring : Specialist or hospital only
Comment : These medicines should be prescribed by clinicians in a hospital setting only for the duration of treatment (primary care prescribing is not appropriate). Prescribing and monitoring should be retained within the hospital setting by an appropriate clinician and the medicines supplied by the hospital for the duration of treatment. In exceptional circumstances a GP may be asked to prescribe/administer but the specialist must provide adequate information and support and retain overall clinical responsibility.   


Initiation : Specialist only
Repeat Prescribing : Any care setting
Monitoring : As defined in Effective Shared Care Agreement (ESCA)
Comment : Monitoring according to Effective Shared Care Agreement (ESCA) for stabilised patients only. GP agreement should be requested by specialist and confirmed/declined by GP on a patient-by-patient basis BEFORE the transfer of prescribing responsibility.   


Initiation and /or Recommendation : Specialist only
Repeat Prescribing : Any care setting
Monitoring : Any care setting
Comment : Suitability as to whether the medicine should be initiated by the specialist or can be recommended by the specialist for Primary care initiation will be clearly documented in each drug monograph on the formulary. If there is a period of stabilisation before transfer of care this will also be stated. Information sheets to support continued Primary care prescribing will be developed if appropriate. The decision will reflect the agreement of the Area Prescribing Committee.   


Initiation : Any care setting
Repeat Prescribing : Any care setting
Monitoring : Any care setting
Comment : Suitable for non-specialist initiation   


Prescribing in approved, specialist tertiary care settings only  


Available to buy Over-The-Counter. Patients should be advised to purchase if appropriate.   

Non Formulary